
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ARBNc1:NS | NSE | INR | Delayed | |
ARBNc2:NS | NSE | INR | Delayed | |
ARBNc3:NS | NSE | INR | Delayed |
UBS has initiated coverage on Aurobindo Pharma Ltd. (ARBP: IN) with a Sell rating and set a price target of Rs 1,333.00. The firm pointed out that while Aurobindo Pharma has a significant presence in...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review